The molecular basis of the anticancer effect of statins

Area of Science:

• Oncology
• Pharmacology
• Computational Biology

Background:

• Statins are widely prescribed cardiovascular drugs that inhibit HMG-CoA reductase to lower cholesterol.
• Emerging evidence suggests statins possess anticancer properties.
• The precise molecular mechanisms underlying statins' anticancer effects require elucidation.

Purpose of the Study:

• To investigate the anticancer mechanism of statins.
• To identify specific gene targets of statins utilizing the synthetic lethality principle.
• To validate the anticancer efficacy of statins in preclinical cancer models.

Main Methods:

• Computational analysis of approximately 37,000 synthetic lethality (SL) pairs.
• Identification of statins as potential drugs targeting genes within SL pairs associated with metastatic genes.
• In vitro validation of statin efficacy across diverse cancer cell lines.

Main Results:

• Statins were identified as potential agents exploiting synthetic lethality against cancer cells.
• Computational screening revealed statins targeting genes in SL pairs with metastatic genes.
• In vitro experiments confirmed the anticancer activity of statins against various cancer cell lines.

Conclusions:

• Statins exhibit anticancer properties through the exploitation of synthetic lethality.
• This study provides a data-driven drug repurposing strategy for statins in oncology.
• The findings offer a molecular basis for statin's anticancer effects with translational potential.